All News

A patient details the peace he felt in the presence of his oncology nurse while receiving treatment for bladder cancer.

A doctor from the department of radiation oncology at Emory’s Clifton Campus describes a nurse at her institution who goes “above and beyond” her call of duty by training her colleagues and making her patients feel comfortable.

A pancreatic cancer survivor explains how gardening helps him feel at peace.

From a cancer survivor walking 3,000 miles for charity to a runner with cancer crossing the finish line with the help of her teammates, here’s what’s happening in the cancer landscape this week.

Researchers observed no difference in overall and progression-free survival in patients with mantle cell lymphoma who started high-intensity treatment at least 90 days after receiving a diagnosis compared with a non-intensive therapy approach.

As the cancer treatment landscape continues to expand, patients and their caregivers should be aware of the various clinical trials currently being conducted — including studies they can possibly join.

Evidence from a phase 3 trial does not support the addition of Tecentriq to a specific chemotherapy regimen with Avastin for patients with newly diagnosed stage 3 or 4 ovarian cancer.

“Understanding and taking action against racial differences in cancer care and clinical trial participation are made more powerful when we listen to patient voices,” writes one patient with breast cancer.

In this episode of the “CURE® Talks Cancer” podcast, Nicole Body discusses her cancer journey and shares how she found the strength to persevere through treatments and accept the difficult truths.

For patients with early-stage, unfavorable-risk Hodgkin lymphoma, this treatment option may allow for the reduction or elimination of radiotherapy in patients without malignant disease.

The study results, according to the authors, suggest that the combination of folinic acid plus the chemotherapies fluorouracil and oxaliplatin should become the standard-of-care therapy in patients with advanced biliary tract cancer whose disease progressed with cisplatin and gemcitabine.

The effectiveness of the Pfizer-BioNTech COVID-19 vaccine increased significantly among patients with cancer who received a vaccine booster 21 days after receiving the first dose.

“Summer finds many of us outdoors and during that time, it’s important to protect our skin from the dangerous rays of the sun,” writes one breast cancer survivor. Learn more about how to use sunscreen, protect your skin and avoid skin cancer.

Adolescent and young adult cancer survivors were more likely to misuse substances including drugs and alcohol compared with their peers without a history of cancer, which may be a result of overprescribing from doctors or inefficient pain management.

Researchers have developed Myeloma Drug Sensitivity Testing to determine which medications will be most effective with minimal side-effects.

This maintenance therapy approach approved progression-free survival without a major impact on quality of life in patients with newly diagnosed ovarian cancer with a BRCA mutation who recently responded to chemotherapy.

Some of the most popular YouTube videos about bladder cancer are of poor quality, spread misinformation and have commercial bias.

A woman with metastatic breast cancer shares a story about a woman with the same diagnosis and a recipe that was distantly inspired by their conversation.

In an accompanying editorial to the recently updated U.S. Preventive Services Task Force recommendation for colorectal cancer screenings, doctors suggested additional measures that would help increase the screening rate among eligible adults and potentially lower the mortality rate.

Vulnerable older patients with advanced ovarian cancer do not respond well to carboplatin treatment alone compared to a combination with paclitaxel.

Scientists have identified a potentially valuable genetic target in children with acute myeloid leukemia that could lead to further studies in immunotherapy drugs for the disease.

On social media, CURE® recently asked its readers to share what unexpected, non-treatment-related costs they incurred during their cancer journey. Here’s what they shared.

A retirement counselor with bladder cancer shares the story of his diagnosis and his thoughts on treatment.

Factors such as race, smoking, longer survival time and treatment may affect the voice and speech production of survivors of oropharyngeal cancer.

A fellow nurse describes how her colleague is a healing presence to not only her patients but also the clinical team.

A survivor of multiple cancers over the span of 27 years expresses her feelings about her cancer journey through a poem.

A nurse practitioner strives to provide tailored care to children with cancer and their families when they are receiving treatment and supportive services.

A cancer survivor explains how she finds time to be productive while dealing with exhaustion.